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Abstract
It is well established that L-proline has several roles in the biology of trypanosomatids. In Trypanosoma cruzi, the etiological
agent of Chagas’ disease, this amino acid is involved in energy metabolism, differentiation processes and resistance to
osmotic stress. In this study, we analyzed the effects of interfering with L-proline metabolism on the viability and on other
aspects of the T. cruzi life cycle using the proline analogue L- thiazolidine-4-carboxylic acid (T4C). The growth of
epimastigotes was evaluated using different concentrations of T4C in standard culture conditions and at high temperature
or acidic pH. We also evaluated possible interactions of this analogue with stress conditions such as those produced by
nutrient starvation and oxidative stress. T4C showed a dose-response effect on epimastigote growth (IC50=0.8960.02 mM
at 28uC), and the inhibitory effect of this analogue was synergistic (p,0.05) with temperature (0.5460.01 mM at 37uC). T4C
significantly diminished parasite survival (p,0.05) in combination with nutrient starvation and oxidative stress conditions.
Pre-incubation of the parasites with L-proline resulted in a protective effect against oxidative stress, but this was not seen in
the presence of the drug. Finally, the trypomastigote bursting from infected mammalian cells was evaluated and found to
be inhibited by up to 56% when cells were treated with non-toxic concentrations of T4C (between 1 and 10 mM). All these
data together suggest that T4C could be an interesting therapeutic drug if combined with others that affect, for example,
oxidative stress. The data also support the participation of proline metabolism in the resistance to oxidative stress.
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Introduction
The protozoan parasite Trypanosoma cruzi is the causative agent
of Chagas’ disease, which affects approximately 12–14 million
people in endemic areas throughout Mexico, Central, and South
America [1]. The illness is characterized by an acute phase with
patent parasitemia and non-specific symptoms (if any), followed by
a life-long chronic phase with subpatent parasitemia and scarce
tissue parasitism. In the symptomatic phase, the heart is primarily
affected, developing hypertrophy and dilatation, in addition to the
digestive tract – predominantly the esophagus and large intestine –
with the appearance of megaviscera [2]. At present, the available
therapy is mainly successful during the acute phase of the disease
but with systemic side effects. Application of this therapy to treat
the chronic phase of the disease – when most patients are
diagnosed – is still controversial [3,4].
T. cruzi has a complex life cycle characterized by several forms
in vertebrate and invertebrate hosts [5,6]. In the invertebrate host
(the triatomine insect belonging to the family Reduviidae, order
Hemiptera), the parasite replicates as a non-infective form called
epimastigote, which can differentiate into a metacyclic trypomas-
tigote, an infectious but non-replicative form. This process is called
metacyclogenesis. When these forms infect a vertebrate host, they
invade host cells and differentiate into amastigotes, which then
divide in the cell cytoplasm and differentiate again into
trypomastigotes, passing through a transient epimastigote-like
stage termed the intracellular epimastigote [7,8,9]. The main
transmission route of the parasite is via insect vector bites on any
region of the host skin. During its feeding, the insect vector
deposits feces and urine containing metacyclic forms, which are
usually self-inoculated by the host when scraping the wound
caused by the insect bite [10].
The successful survival of the parasite in different environments
throughout its life cycle (e.g. the vector intestinal tract, the
mammalian host blood stream and the host cell cytoplasm) depends
on its ability to maintain intracellular homeostasis of ions and
nutrients and the ability to catabolize different substrates to obtain
energy. Thus, the activity of transporters allowing the uptake of
solutes across the parasite cytoplasmic membrane and the metabo-
lism of certain amino acids are crucial processes at various points in
the T. cruzi life cycle [11,4,12]. Among these nutrients, several amino
acids play important roles in many biological processes. Some
metabolic pathways are particularly important under stress situations
such as the interconversion between arginine and phosphoarginine
b yt h ee n z y m ea r g i n i n ek i n a s e[ 13]. This enzyme is regulated
throughout the different growth phases [14] and is involved in
resistance to pH and nutritional stress conditions [15] and in
oxidative stress [16]. Other examples include the involvement of
glycine, alanine, proline and glutamate in osmoregulation and cell
volume control during all stages of the parasite [17,18], in addition to
t h eu s eo fp r o l i n e ,g l u t a m a t ea n da s p a r t a t ea se n e r g ya n dc a r b o n
sources [19] and in the metacyclogenesis process [20]. In particular,
PLoS ONE | www.plosone.org 1 February 2009 | Volume 4 | Issue 2 | e4534L-proline is an important metabolite that is involved in the
differentiation of intracellular epimastigote to trypomastigote forms,
whichisrequiredfortheestablishment ofinfectioninthe mammalian
host [9].
Previous work showed that L-proline was taken up from the
extracellular environment through two active transporters [21]
and converted into five intermediates of the Krebs cycle (e.g.,
citrate, isocitrate, malate, succinate and oxaloacetate), pyruvate
and the amino acids glutamate and aspartate, which are rapidly
metabolized [19]. This seemed to comprise a conventional proline
oxidation pathway. This idea is supported by the presence of two
putative genes encoding proline oxidases and one putative gene
encoding a pyrroline-5-carboxylate dehydrogenase annotated in
the T. cruzi genome database [4]. Since L-proline participates in
several differential processes in T. cruzi with respect to mammalian
host cells, we hypothesize that inhibition of proline metabolism in
T. cruzi could have more severe effects on the parasite biology that
on host cells.
Various L-proline analogues such as T4C have been used as
inhibitors of proline metabolism in prokaryote and eukaryote
organisms [22,23,24]. In the present study, we analyzed the effects
of T4C on the growth of epimastigotes and the infection of
mammalian cells by T. cruzi. We also investigated the synergism or
antagonism of T4C with stress conditions faced by T. cruzi during




L-proline, a relevant energy source in trypanosomatids, is
metabolized and converted into five intermediates of the
tricarboxylic acid cycle (e.g., citrate, isocitrate, malate, succinate
and oxaloacetate) through its oxidation to glutamate in T. cruzi [4].
Analogues of proline could be useful for inhibition of enzymes of
this and other metabolic pathways. Among these analogues, L-
thiazolidine-4-carboxylic acid, a product of the non-enzymatic
condensation of equimolar quantities of formaldehyde and L-
cysteine to yield the saturated imino acid containing S as a
thioether [25], has the ability to interfere with the utilization of
proline for protein synthesis and to mimic proline in its
incorporation into proteins [26]. It can be metabolized in both
bacterial and mammalian cells [26,27,28].
In order to investigate a possible trypanocide or trypanostatic
effect of T4C on T. cruzi, 2.5610
6 epimastigotes per ml were
cultured in the presence of different concentrations of T4C,
ranging from 0.1 to 1 mM. The growth of epimastigotes on LIT
medium with or without 200 mM rotenone and 0.5 mM antymicin
were also followed as controls. The epimastigotes reached the
stationary phase on the tenth day of growth, with 94610
6 cells/ml
in LIT. T4C showed a dose-dependent inhibition of epimastigote
growth at 28uC and pH 7.5, the standard temperature and pH for
cultivating these cells. The observed growth differences between
the treated cells and the LIT control were significant (p,0.01), and
the IC50 was determined to be 0.8960.02 mM (Figure 1),
demonstrating an effect of T4C on T. cruzi epimastigotes.
It has been suggested that T4C inhibits the growth of Escherichia coli
due to its specific interference with L-proline for protein synthesis by
substituting L-proline in the corresponding prolyl-tRNA [27]. It has
also been suggested that T4C could inhibit the synthesis of proline,
thus enhancing the incorporation of this analogue into proteins [26].
In addition, when Escherichia coli is grown in a proline-free medium,
the cells are able to actively oxidize T4C, and the product of this
oxidation can be used as a carbon source for synthesis of the
Figure 1. Growth curve of epimastigotes of Trypanosoma cruzi treated with T4C at 28uC and 7.5 pH: & 0 mM, D 0.1 mM, # 0.25 mM,
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cells, T4C is oxidized by mitochondrial proline oxidase to L-
thiazoline-4-carboxylic acid, which is then hydrolyzed to N-formyl-
cysteine and later hydrolyzed to cysteine and formic acid by a
cytosolic enzyme [28]. Likewise, T4C inhibited proline synthesis in
the wilted leaves of plants that synthesize and accumulate proline
rapidly during water stress conditions [29]. This inhibition had no
effect on D
1-pyrrolidine-5-carboxylic acid reductase (the enzyme that
converts D
1-pyrrolidine-5-carboxylic acid into proline). On the other
hand, T4C had no influence on the incorporation of proline into
proteins in plants. In addition, these authors found that concentra-
tions between 0.2 and 1 mM T4C inhibited proline oxidation in
mitochondria isolated from etiolated barley, and this inhibition was
related to the activity of proline dehydrogenase and not the transport
of proline into the mitochondrial matrix.Allinformations suggest that
the inhibitory activity of T4C on T. cruzi growth could be due to any
of the mentioned processes in which proline participates.
Interaction with stress conditions
T. cruzi, as well as other parasitic organisms that cycle among
different conditions and environments, must deal with radical
physical, chemical and physicochemical variations such as
temperature, availability of nutrients, oxidative stress and pH, all
constituting stress factors. The interaction of T4C with these stress
factors could identify a possible role for proline metabolism in T.
cruzi biology, so we analyzed this interaction. As proline
metabolism is involved in resistance to several stress conditions
in a variety of organisms ranging from yeast to plants [30,31,32],
we investigated if this amino acid could also be involved in
resistance to such unevaluated stress conditions in T. cruzi.W e
initially evaluated the effects of T4C together with high
temperature (33uC and 37uC), acidic pH (5.5 and 6.5), stress
from nutrient deficiency (incubation in the presence of PBS
supplemented or not with several carbon sources such as amino
acids or glucose) and oxidative stress due to different reactive
oxygen species (incubation in the presence of H2O2).
1) Temperature stress
As already mentioned, T. cruzi goes through temperature changes
throughout its life cycle because the insect vector does not regulate its
body temperature and because it alternates between an insect vector
and a mammalian host. Therefore, this parasite faces environmental
temperature variations and the high temperature of the mammalian
body (up to 37uC). Epimastigotes grow optimally at a temperature of
28uC, a condition in which a cell density of 94610
6 cells/ml was
reached at the stationary phase. Our data showed, however, that cell
growth reached a higher density at 33uC (120610
6 cells/ml), while
cell growth at 37uC was even less than that obtained at 28uC( 7 0 610
6
cells/ml). These results are in opposition to those obtained by [33], in
which researchers reported an optimal temperature of epimastigote
growth between 20uCa n d2 8 uC .T h es i m u l t a n e o u se f f e c t so fT 4 C
and 33uCo r3 7 uC diminished cell density in relation to that observed
at 28uC( F i g u r e1 ) .T h eI C 50 values were calculated, being
0.8360.07 mM and 0.5460.01 mM for 33uCa n d3 7 uC, respec-
tively (Figures S1, S2, S3, supplementary material). The simultaneous
treatment with 0.5 mM of T4C and 37uC evidenced an effect for
both variables that was significantly higher than the additive effects of
T4C and temperature by themselves (Figure 2a), showing a
synergistic interaction between these variables (p,0.05).
2) pH stress
T. cruzi also faces pH variations throughout its life cycle. In the
intestinal tract of the insect vector, the pH varies between 5.9 and
8.9, depending on the starvation and blood meal periods [34].
About 2 months after feeding, the pH of triatomine excreta is
acidic, and the parasite population in the feces is mostly
constituted of metacyclic trypomastigotes. After feeding, the pH
of excreta switches to alkaline, and one to five days later, it returns
to a slightly acidic pH. During these periods, the population of
epimastigotes increases, and the trypomastigotes and spheromas-
tigotes forms are less common [35]. In addition, the metacyclic
infective forms living in an acidic medium must face a slightly
alkaline medium in the blood or inside the cell cytoplasm. Given
this situation, it seemed interesting to evaluate how the parasites
responded to acidic pH in the presence or absence of T4C.
Epimastigotes were grown at pH 5.5, 6.5 and pH 7.5 as a control
(i.e., the usual pH of LIT medium). It was found that their growth
was strongly inhibited at pH 5.5, giving a maximum cell density of
21610
6 cells/ml in LIT medium, while parasites grown at pH 6.5
achieved similar cell densities (102610
6 cells/ml at the stationary
phase) to those seen at pH 7.5 (94610
6 cells/ml) (Figure 2b).
When the cultures were treated with T4C, the inhibitory effect on
parasite growth was enhanced. It was observed that growth
inhibition in the presence of T4C at pH 5.5 and 6.5 was stronger
than at pH 7.5 (Figure 1). The IC50 values were calculated, being
0.5860.03 mM at pH 5.5 and 0.5160.03 mM at pH 6.5 (Figures
S4, S5, S6, supplementary material). However, an interaction
between the proline analogue and these growth conditions could
not be confirmed, since the statistical test used to evaluate
synergism was not significant (p.0.05). This result suggests that
proline metabolism is not involved in pH stress resistance
mechanisms.
3) Nutritional stress
Nutritional stress also occurs regularly during the T. cruzi life
cycle, particularly in the gut terminal portion, where metacyclo-
genesis occurs [20]. It is well established that T. cruzi epimastigotes
can metabolize not only proline, but also glucose, glutamate and
aspartate. These energy sources are able to support the parasite
survival to some extend after PBS starvation [19]. After nutritional
stress, these metabolites are the fuel that energetically supports the
parasite differentiation into the infective metacyclic forms [20,36].
In order to analyze the possible effects of T4C on nutritionally
stressed parasites, 20610
6 cells/mL in the exponential growth
phase were starved for 72 h in PBS (PBS) or in 3 mM L-proline in
PBS (PRO). Both cultures were treated or not (controls) with T4C,
then cell viabilities were determined using the MTT assay. As
expected, the presence of 3 mM proline in the PBS increased
parasite viability when compared with parasites starved in PBS.
Both cultures treated with T4C showed significant differences
(p,0.01) compared to their respective controls (not treated with
T4C), with a greater difference in the parasites maintained with L-
proline (93%) compared to PBS (38%) (Figure 2c). This could be
attributed due to either differences in the metabolic state of the
cells or to a specific interference of T4C with proline metabolism.
To clarify this point, a culture was also starved for 72 h with
3 mM glucose in PBS (GLC), then treated or not with T4C. As
was observed (Figure 2c), treatment with T4C resulted in a 56%
loss of viability, confirming that the effect of this analogue was
higher in metabolically active parasites. The three situations of
nutritional stress, however, showed a significant reduction in
survival in the presence of T4C (p,0.01). Between these two
essential nutrients incorporated in PBS, the most significant effect
was obtained with glucose because it served as a carbon and
energetic source. Other carbon and energy sources such as
aspartate and glutamate could also have the same effect, since they
seem to be as relevant as glucose or proline for the parasite survival
in nutritional stress conditions [4,19]. In spite of the various
Trypanosoma cruzi Chemoterapy
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order to generate free metabolites within the cell [37,15], the
viability of epimastigotes after 72 h was very low in PBS
conditions.
4) Oxidative stress
In order to study the possible interaction between T4C and
oxidative stress, we first evaluated the dose-response of the
epimastigotes to different concentrations of H2O2. Cells (5610
6
parasites/mL) were resuspended in PBS and challenged with
different hydrogen peroxide concentrations (between 0 and
200 mM) at 28uC for 90 min. After removal of the H2O2, cells
were re-inoculated in fresh-LIT medium, and their growth was
evaluated, as described in Materials and Methods. The concen-
tration of H2O2 inhibiting 50% of parasite growth (IC50) was
determined to be 160 mM under our experimental conditions. To
determine the effects of H2O2 on T4C treatment, cells were then
incubated under oxidative stress conditions (IC50) or in PBS in the
presence or absence of 0.5 mM T4C, and parasite growth was
followed (Figure 2d). The differences between each treatment
(H2O2 or T4C) and its respective control were significant (p,0.01).
The number of cells previously challenged with T4C was reduced
by 55% with respect to the control, and cells incubated
simultaneously in T4C and H2O2 showed a 75% reduction in
growth. The protective effect of L-proline against oxidative stress
was previously reported by some authors, such as [30] and [38].
Taking into account the effects of T4C on mammalian infection, it
is possible that this could cause increased inhibition of the viability
of infective forms. It was known that T. cruzi could generate
different reactive oxygen species (ROS) by its own aerobic
metabolism and the host immune response. These species lead
to membrane disruption, inactivation of essential enzymes,
mutagenesis and damage to the DNA repair machinery. The
importance of these effects is primarily seen when the parasite
invades the mammalian cell or when it is exposed to drugs used to
treat Chagas’ disease [39]. In the same way, T4C could act as a
drug that increases the inhibitory effect of H2O2. In spite of the
ROS detoxifying mechanisms in T. cruzi [40,16], the epimastigote
survival was low, at 0.5 mM T4C.
From the results presented above, it could be proposed that the
enhanced effect of T4C in the presence of H2O2 was due to the
fact that this reagent affected a proline-dependent oxidative stress
Figure 2. Response of epimastigotes at different stress conditions and T4C treatment. Panel a: the parasite density was measured at the
5
th. day of growth, submitted or not to thermal stress (33uC and 37uC) and drug treatment (0.5 mM T4C). Panel b: the parasite density was measured
at the 5
th. day of growth, submitted or not to pH stress (pH 5.5 or 6.5) and drug treatment (0.5 mM T4C). Panel c) the parasite viability was measured
by MTT assay after nutritional stresses performed by 72 h incubation in PBS, PRO and GLC, combined or not with the treatment with drug (0.5 mM
T4C). Panel d: the parasites were submitted to oxidative stress by incubation in the presence of 160 mMH 2O2 and the addition or not of drug (0.5 mM
T4C). The effect of treatments and controls were measured by growing the parasites in LIT for five day and cell density, quantified.
doi:10.1371/journal.pone.0004534.g002
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enhancement of the effects of T4C seen under oxidative stress
conditions was due to the fact that T4C made the cells more
fragile by partially arresting proline metabolism, which is relevant
for energy generation [19] and redox balance, as occurs in other
organisms [30,41,38]. To better understand both the involvement
of proline metabolism in resistance to oxidative and metabolic
stresses and the interaction between these factors and T4C
treatment, a three-variable experiment was performed: cell
viability was evaluated as a function of oxidative and metabolic
stress challenges and T4C treatment. Preliminary results forced us
to diminish the metabolic stress by diminishing the starvation time
from 72 (the time used above for metabolic stress experiments) to
48 h, since 72 h of starvation combined with oxidative stress and
T4C treatment reduced viability to immeasurable levels. The
parasites (20610
6 cells/mL) were incubated for 48 h in PBS,
supplemented or not with 3 mM proline. As done previously,
cultures maintained in PBS supplemented with 3 mM glucose
were also evaluated. All groups were maintained in the presence or
absence of 0.5 mM T4C (T4C), and the cultures were then
challenged with H2O2, as previously described, or mock
challenged with H2O. The cell viability in each case was evaluated
by a MTT assay. Before the 3 h challenge (T0), the viability of
parasites incubated with carbon sources (proline or glucose)
differed significantly (p,0.01) from the viability of those incubated
with PBS (Figure 3). As expected, T4C showed a synergistic effect
with each nutrient condition: the cell viability was diminished by
75%, 88% and 62% in parasites starved with PBS, PRO and
GLC, respectively. After a 3 h mock challenge, cell viability
diminished between 33% and 55% with respect to T0, showing
significant differences (p,0.01) in all of the treatments. When the
T4C-treated parasites were challenged with H2O2, a significant
reduction in viability was observed (p,0.01) compared to parasites
that were mock challenged (Figure 3). Interestingly, the difference
was not significant between the PRO or GLC groups. This pattern
changed, however, when T4C was present, showing a reduction in
cell viability after 3 h of incubation with H2O2 of 21% for PBS,
57% for PRO and 85% for GLC with respect to parasites not
incubated under oxidative stress. Only simultaneous treatment
with PRO-T4C and oxidative stress showed a significant
difference with respect to PRO and oxidative stress (p,0.05).
The enhanced effect of T4C on the PRO group with respect to
the GLC group was expected and could be explained by the fact
that T4C interfered with proline rather than glucose metabolism. In
order to confirm this, we measured the intracellular free-proline
levels in parasites starved for 48 h with PBS or 3 mM proline, in the
presence or absence of T4C. Parasites starved with 3 mM glucose
were used as controls, as previously described. After 48 h of
incubation (T0), the intracellular free proline concentration was
twice as high in the PRO group compared to the GLC group (4.52
and 2.26 mM/10
6 cells, respectively) (Figure 4), indicating that
when available, this metabolite could be transported and accumu-
lated, as previously reported [21]. It is worth stressing that no
differences were observed in cell viability between the PRO or GLC
groups (p,0.05) (Figure 3). After 48 h of incubation (T0), the
concentration of intracellular L-proline in the presence of T4C was
maintained (PBS=0.88 mM/10
6 cells) or reduced (PRO=
2.87 mM/10
6 cells, GLC=1.29 mM/10
6 cells) with respect to
incubation without the analogue (Figure 4). The effect of the
oxidative stress on the intracellular proline level was also evaluated
by treating the cells with H2O2 (or H2O as mock stress) for 3 h.
There were significant differences (p,0.01) in the intracellular L-
proline concentration between the cells kept under oxidative stress
and in the presence of T4C. These two results confirm the
synergistic effects of T4C and oxidative stress. Higher sensitivity to
H2O2 of the cells maintained in PRO/T4C with respect to those
Figure 3. The effect of oxidative stress on epimastigotes previously incubated in PBS (PBS), L-proline 3 mM in PBS (PRO), and 3 mM
Glucose in PBS (GLC), were treated or not with 0.5 mM T4C (PBS+T4C, PRO+T4C and GLC+T4C). After washing, the parasites were
incubated for 3 h in PBS and stressed with 160 mMH 2O2. The cells viability was evaluated by MTT assay.
doi:10.1371/journal.pone.0004534.g003
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proline levels rather than to inhibition of its metabolism.
T. cruzitakesup proline throughtwoactive transportsystems, one
of them being a high affinity, low capacity transporter called system
A, and the other a low affinity high capacity transporter called
systemB[21].Tofurtherclarifythefact thatL-prolineisdiminished
by the presence of T4C, we performed a proline transport
competition assay. Since T4C is a structural analogue of proline,
the assay was designed under the hypothesis of a competitive
inhibition, thus proline was used at concentrations in the range of
the Km for each transport system, and T4C as a competitor was
used at near its IC50 (0.5 mM) concentration for both assays. As can
be observed, both transporters resulted partially inhibited (68%
inhibition for system A and 91% inhibition for system B) (Figure 5).
In turn, the proline dehydrogenase and proline racemase activities
were not inhibited (data not shown).
Effect of T4C on trypomastigotes bursting from infected
host cells
In order to evaluate the effectiveness of treating the infected host-
cells, the toxicity of T4C on mammalian CHO-K1 cells was
determined. Interestingly, the inhibitory T4C concentrations tested
on epimastigotes (between 0.1 and 1.0 mM) were not toxic to
mammalian cells (IC50=11.460.36 mM) (Figure 6). It is worth
mentioning that epimastigotes of T. cruzi are not infective stages, but
they serve as a model to analyze whether similar effects would be seen
in the infective trypomastigote stage. Therefore, the effects of the
treatment of infected CHO-K1 cells were evaluated using concen-
trations up to 10 mM, causing a reduction of 31% and 56% in
parasite bursting (Figure 7). The highest T4C concentration used to
analyze survival through the intracellular stages of the parasite and
the following release of trypomastigotes was 10 mM. The mamma-
lian cells were then infected and treated with different concentrations
of T4C (between 1.0 and 10.0 mM). After five days of infection, the
number of trypomastigotes that burst into the extracellular control
medium was approximately 3.1610
6 cells/ml. The parasite concen-
tration in the presence of T4C was reduced to between 1.4610
6
cells/ml and 2.1610
6 cells/ml (Figure 7). There were significant
differences between drug treatment and the control (p,0.05).
Proline is a relevant metabolite in T. cruzi biology, involved in
several processes that are essential for the parasite life cycle [4].
Among them, differentiation in the insect vector stages [20] and
inside the mammalian cell [9], as well as energy metabolism [19],
seem to be of relevance. Taken together, these data are
encouraging for the use of proline analogues able to inhibit the
proline transport activity., on one side to identify new lead
compounds for Chagas’ disease therapy, and on the other side, to
validate the metabolite transporters as drug targets [4,12]. Further
experiments are in process to analyze the synergic effects of T4C
combined with nifurtimox and benznidazole, the drugs presently
in use to treat this infection, with the aim of reducing their doses
and perhaps diminishing their undesired side effects.
Materials and Methods
Reagents
L-proline, L-thyazolidine-4-carboxylic acid, rotenone, antimy-
cin and MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazo-
lium bromide) were from Sigma (Saint Louis, MO, USA). L-[2,
3, 4, 5-
3H] proline, 100 Ci/mmol was purchased from NEN Life
Science Products (Boston, MA USA). RPMI culture medium and
Fetal Calf Serum were from Cultilab (Campinas, SP, Brazil). All
other reagents were from Amresco.
Cells and parasites
The Chinese Hamster Ovary cell line CHO-K1 was routinely
cultivated in RPMI medium supplemented with 10% heat-
Figure 4. The intracellular proline concentration was measured as a function of nutrient starvation, oxidative stress and T4C
treatment. The epimastigotes were incubated for 48 h in PBS (PBS), 3 mM L-proline (PRO) and 3 mM Glucose (GLC), supplemented or not with
0.5 mM T4C (PBS+T4C, PRO+T4C and GLC+T4C) (T0). After washings, the parasites were incubated along 3 h in PBS in the presence or not of 160 mM
H2O2, and the intracellular concentration of proline was measured.
doi:10.1371/journal.pone.0004534.g004
Trypanosoma cruzi Chemoterapy
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units mL
21 penicillin and 100 mgm L
21 streptomycin at 37uCi na
humid atmosphere containing 5% CO2. Epimastigotes of T. cruzi,
CL strain, clone 14 [42], were maintained in the exponential
growth phase by subculturing every 48 h in LIT (liver infusion-
tryptose) medium supplemented with 10% FCS at 28uC [43].
Figure 5. The effect of 0.5 mM T4C on L-proline uptake in epimastigotes of T. cruzi. Proline transport was measured at proline
concentrations corresponding to the Km values for system A (0.31 mM) and system B (1.36 mM).
doi:10.1371/journal.pone.0004534.g005
Figure 6. The effect of T4C on CHO-K1 line cells viability. CHO-K1 cells were challenged with different concentrations of T4C, and the cell
viability was measured by MTT assay.
doi:10.1371/journal.pone.0004534.g006
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PLoS ONE | www.plosone.org 7 February 2009 | Volume 4 | Issue 2 | e4534Trypomastigotes were obtained by infection of CHO-K1 cells with
trypomastigotes, as described previously [7,9]. Trypomastigotes
were collected in the extracellular medium from five days onward.
Growth inhibition assays
Epimastigotes in the exponential growth phase (approximately
50610
6 cells/mL) were washed three times by centrifugation and
resuspended in phosphate buffered saline (PBS), then cultured in
fresh-LIT medium supplemented or not (controls) with different
concentrations of T4C ranging from 0.1 to 1.0 mM at 28uC. The
assayswere carried out in96 wellplates by inoculating 2.5610
6 cells/
mL in 200 mL of medium. Cell growth was estimated by absorbance
readings at 620 nm every day for ten days. The absorbance was
transformed into a cell density value (cells/mL) using a linear
calibration equation previously obtained under the same conditions
(R
2=0.9981, p,0.05). The concentration of T4C that inhibited 50%
of parasite growth (IC50) was determined in the exponential growth
phase (sixth day) by adjusting the effect (growth inhibition values) as a
function of T4C concentration to a classical sigmoidal equation. As a
cell growth inhibition control, growth curves in which 200 mM
rotenone and 0.5 mM antimycin were added to the culture medium
were run in parallel for all experiments.
The effect of T4C on growth inhibition under stress
conditions
To analyze the combined effect of T4C at different pH values
and at different temperatures, the growth curves were generated as
described above, with adjustment of the LIT pH to the desired
values or by incubating the cultures at 28uC (no stress), 33uCa n d
37uC. To evaluate the effect of T4C combined with nutritional
stress conditions, 20610
6 parasites/mL were washed and resus-
pended in 0.5 mM T4C in PBS (Phosphate Buffered Saline) or PBS
supplemented with 3 mM glucose, 3 mM proline, or nothing (as
control)for72 hinEppendorftubes.Subsequently,cellviabilitywas
estimated by the MTT assay. To evaluate the combined effect of
T4C and oxidative stress, 5610
6 parasites/mL in the stationary
phase were maintained for 1 h and 30 min at 28uC in PBS or with
160 mMH 2O2 in the presence or absence of 0.5 mM T4C. The
cells were then collected by centrifugation and resuspended in LIT
medium, and after 5 days, the number of cells/mL was determined
as described previously [44]. A second experiment was carried out
to evaluate the protective effects of L-proline and glucose (used as a
control) on parasite viability under oxidative stressinthe presenceof
T4C. In this experiment, 20610
6 epimastigotes/mL were washed
twice, resuspended in PBS and pre-incubated for 48 h in PBS in the
presence or absence of 3 mM L-proline and 3 mM glucose, with or
without 0.5 mM T4C. After pre-incubation, the cells were washed
twice, resuspended in PBS with or without 160 mMH 2O2 and
maintained under those conditions at 28uC for 3 h. Cell viability
was then estimated using the MTT assay [45]. The L-proline
concentration was measured before and after oxidative stress as
previously described. To quantify free intracellular L-proline, the
parasites were washed in cold PBS, suspended in 1 ml of PBS and
lysed by sonication. The lysate was centrifuged (100,000 g, 30 min),
and the supernatant was freed of proteins by trichloroacetic acid
precipitation followed by centrifugation at 20,000 g for 30 min.
Measurements of intracellular L-proline were made using the
remaining supernatant solution, as described by Bates [46].
Proline uptake and enzymatic activities
The proline competition assays were performed as previously
described [47]. In brief: two-day cultured parasites were washed
three times by centrifugation and resuspended in phosphate
Figure 7. The effect of T4C on the trypomastigote bursting was evaluated. The trypomastigotes bursted at 5
th. day post-infection in cell
cultures treated or not with at different concentrations of T4C were counted.
doi:10.1371/journal.pone.0004534.g007
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6 cells/
ml and distributed in aliquots of 100 ml (containing 20610
6 cells
each). Transport assays were initiated by the addition to the assay
tubes of 100 ml of radioactively traced proline (0.5 mCi) to a final
concentration of 0.31 mM or 1.36 mM, supplemented or not with
0.5 mM T4C. V0 was measured at 28uC for 30 s, and proline
transport was stopped by addition of 800 ml of cold 50 mM
proline in PBS, and rapid washing by centrifugation at 10,000 g
for 60 s. The T. cruzi proline dehydrogenase activity was assayed
as previously described [48]. Proline racemase was assayed in T.
cruzi extracts by performing a coupled reaction, using D-proline as
the enzyme substrate and L-proline dehydrogenase as the
revelation system. Both assays were performed in the presence
or absence of 0.5 mM T4C.
Effect of T4C on mammalian cell viability
CHO-K1 cells (5.0610
5 cells ml
21) were inoculated in 24-well
plates in FCS supplemented RPMI medium, as previously
described, in the presence of increasing concentrations of T4C
or no T4C (controls). The viability of cells was determined by the
MTT assay, and the IC50 was obtained by fitting the data to a
typical dose-response sigmoidal curve.
Effect of T4C on trypomastigote bursting
CHO-K1 cells were grown on cover slips and infected with
trypomastigotes in RPMI medium supplemented with 10% FCS.
After 3 h at 37uC, free trypomastigotes in the medium were
removed by washing with PBS, and the infected cells were
maintained at 33uC in RPMI medium supplemented with 2%
FCS, with or without different concentrations of T4C. These
concentrations of T4C were not toxic to the mammalian cells. The
trypomastigotes were collected in the extracellular medium on the
fifth day and counted in a hemocytometer [9].
Statistical analysis
A one-way ANOVA followed by Dunnet’s test was used for
statistical analysis. To analyze synergism between two independent
treatments, a two-way ANOVA was performed as described
previously [49]. A p value that was less than 0.05 was considered
statistically significant.
Supporting Information
Figure S1 Growth curve of epimastigotes of Trypanosoma cruzi
treated with T4C at 33uC and 7.5 pH: & 0 mM, n 0.1 mM, #
0.25 mM, X 0.5 mM, % 0.75 mM, m1.0 mM. Inhibition control
(’) was performed by incubation the parasites in the presence of
0.5 mM antimycin and 200 mM rotenone.
Found at: doi:10.1371/journal.pone.0004534.s001 (0.48 MB
TIF)
Figure S2 Growth curve of epimastigotes of Trypanosoma cruzi
treated with T4C at 37uC and 7.5 pH: & 0 mM, n 0.1 mM, #
0.25 mM, X 0.5 mM, % 0.75 mM, m 1.0 mM. Inhibition
control (’) was performed by incubation the parasites in the
presence of 0.5 mM antimycin and 200 mM rotenone.
Found at: doi:10.1371/journal.pone.0004534.s002 (0.45 MB TIF)
Figure S3 Sigmoidal dose-response curve of epimastigotes of
Trypanosoma cruzi. Percentage of growth inhibition of T. cruzi
epimastigotes at different temperatures and T4C. The curves
represent the sigmoidal equation at 28uC (—), 33uC (---), and 37uC
(NNNNNNNNNNNNNNNN). It also shows the maximum cell growth obtained in
the control at each condition of temperature (inset).
Found at: doi:10.1371/journal.pone.0004534.s003 (0.53 MB TIF)
Figure S4 Growth curve of epimastigotes of Trypanosoma cruzi
treated with T4C at 28uC and 5.5 pH: & 0 mM, n 0.1 mM, #
0.25 mM, X 0.5 mM, % 0.75 mM, m1.0 mM. Inhibition control
(N) was performed by incubation the parasites in the presence of
0.5 mM antimycin and 200 mM rotenone.
Found at: doi:10.1371/journal.pone.0004534.s004 (0.55 MB TIF)
Figure S5 Growth curve of epimastigotes of Trypanosoma cruzi
treated with T4C at 28uC and 6.5 pH: & 0 mM, n 0.1 mM, #
0.25 mM, X 0.5 mM, % 0.75 mM, m1.0 mM. Inhibition control
(’) was performed by incubation the parasites in the presence of
0.5 mM antimycin and 200 mM rotenone.
Found at: doi:10.1371/journal.pone.0004534.s005 (0.45 MB
TIF)
Figure S6 Sigmoidal dose-response curve of epimastigotes of
Trypanosoma cruzi. Percentage of growth inhibition of T. cruzi
epimastigotes at different temperatures and T4C. The curves
represent the sigmoidal equation at pH 7.5 (’), 6.5 (---), and 5.5
(NNNN). It also shows the maximum cell growth obtained in the
control at each condition of pH (inset).
Found at: doi:10.1371/journal.pone.0004534.s006 (0.53 MB TIF)
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